-
Study aim
-
To determine the efficacy of Platelet Rich Plasma (PRP) versus 5% topical minoxidil for the treatment of androgenetic alopecia
-
Design
-
randomized control trial(RCT) parallel group,single blinded study 35 patients will be assign in each group,radomization will be done by lottery method,a single center study
-
Settings and conduct
-
PNS Shifa karachi after approval from ethical committee,blinding is done for photographic examination,as mentioned earlier
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria Age 18 to 60 years.Patient Hamilton-Norwood grade ≥2 and ≤ 5 or Ludwig scale grade 1-2.Platelets count more than150, 000 /µl.Duration of androgebetic alopecia > 6 months.Patient has not taken any kind of medical treatment for hair loss or has not used treatment for more than 6 months duration.
exclusion criteria Patients with alopecia other than AGA, such as telogen effluvium, alopecia areata, acquired cicatricial alopecia, or anagen effluvium.The patient on warfarin or heparin.The infective disease of the scalp.Patient who has taken any treatment for androgenetic alopecia History of thyroid disorder.Patients with hypersensitivity to minoxidil in past.Any infective skin disease.Pregnancy /lactation.Patient taking aspirin.Unrealistic expectation.
-
Intervention groups
-
30 ml of venous blood will be drawn into a tube containing citrate phosphate dextrose,it will be subjected to centrifugation by two spins to produce PRP .Calcium gluconate to PRP ratio used will be 1:9 this will be injected intradermally,each session 1 month apart. Participants of group B will be advised to apply topical 5% minoxidil 1 ml over dry scalp 12 hourly.
-
Main outcome variables
-
hair pull test ,investigator 7 point score ,patient satisfaction score ,patient standardized hair growth questionnaire,photographic evaluation